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In our original paper we found that the seven genome-wide 
statistically significant genetic determinants of telomere length 
from the largest genome-wide association study of telomere 
length (1) also influence melanoma risk and that their effects on 
both traits were highly correlated (Pearson’s correlation = 0.92), 
clearly establishing the existence of shared biology underlying 
the two traits. However, we concluded that “Our findings do 
not imply that telomere length acts directly on cancer risk and 
could reflect pleiotropic effects of telomere-length loci (such as 
the ease with which telomerase is reactivated in a melanocytic 
nevus).” Despite acknowledging that they are underpowered to 
detect pleiotropy, and indeed without any investigation of plei-
otropy, Shen and Zhang assume that the effect of the single-
nucleotide polymorphisms (SNPs) on melanoma risk is entirely 
mediated by telomere length. This is the crux of the matter: If you 
assume that there is no pleiotropy, then, yes, telomere length is 
a direct determinant of melanoma risk. But making the assump-
tion that leukocyte telomere length (LTL) should have a direct 
impact on melanoma risk seems biologically implausible to us. 
For instance, given that telomere lengths in different tissues are 
highly correlated despite consistent differences in length (2,3,4), 
it is likely that these SNPs influence telomere length in a variety 
of cell types, such that LTL is strongly correlated with telomere 
length in melanocytes. Melanocytic telomere length may then 
have a direct or indirect effect on melanoma risk.
Whether or not you accept the authors’ assumption, extrap-
olating results based on genetic variants that explain only 1.2% 
of the variation in LTL to estimate the effect of LTL directly on 
melanoma risk appears to us overly optimistic, and the con-
fidence intervals reported here do not reflect the huge uncer-
tainty inherent in the modeling assumptions made.
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